Status:
ACTIVE_NOT_RECRUITING
Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention
Lead Sponsor:
Suleyman Demirel University
Conditions:
Acute ST Segment Elevation Myocardial Infarction
Eligibility:
All Genders
18-85 years
Phase:
PHASE3
Brief Summary
The aim of this study is to evaluate the effects of N-acetyl cysteine on major cardiac and cerebral events in patients undergoing primary percutaneous coronary intervention who have moderate to high r...
Eligibility Criteria
Inclusion
- Patients with Acute ST Elevation Myocardial Infarction undergoing Primary Percutaneous Coronary intervention Who Have Moderate to High Risk For Contrast Induced Nephropathy (Mehran Score ≥5)
Exclusion
- Patients \>18 years old with moderate to high risk for contrast induced nephropathy undergoing percutaneous coronary intervention
- Low risk for contrast induced nephropathy (Mehran Score \<5)
- Use of nephrotoxic agents (NSAIDs, aminoglycosides,recent contrast injection...)
- Infection
- Pregnancy, Lactation
- Renal failure requiring dialysis
- Hepatic failure
- Allergy to NAC
- History of Asthma
- Chronic nitrate usage
- Malignancy
- Use of corticosteroids
- Leucocytosis,Thrombocytosis,Anemia
- Blood pressure of \>180/100mmHg despite anti-hypertensive therapy
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01878344
Start Date
January 1 2013
End Date
December 1 2026
Last Update
May 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Suleyman Demirel University
Isparta, Mediterranean Region, Turkey (Türkiye), 32260